Nettles Cory L
Known title: DirectorCIK: 0001323628
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Weyco Group Insider Exercises Options. Katherine Destinon, an executive at Weyco Group, exercised stock options valued at approximately $58,000. This routine corporate action indicates the execution of previously granted equity compensation. The company currently trades with a trailing P/E ratio of 12.6 and offers a dividend yield of 2.90%.
Transaction History
| ASB | ▲ Buy | Grant | 36 | $1K | 9/15/2026 | View on chart |
| ASB | ▲ Buy | Grant | 335 | $10K | 9/15/2026 | View on chart |
| WEYS | ▲ Buy | Grant | 1,265 | $0 | 8/25/2026 | View on chart |
| ASB | ▲ Buy | Grant | 38 | $1K | 6/15/2026 | View on chart |
| ASB | ▲ Buy | Grant | 344 | $10K | 6/15/2026 | View on chart |
| ASB | ▲ Buy | Grant | 404 | $10K | 3/16/2026 | View on chart |
| ASB | ▲ Buy | Grant | 44 | $1K | 3/16/2026 | View on chart |
| ASB | ▲ Buy | Grant | 4,585 | $125K | 2/1/2026 | View on chart |
| ASB | ▲ Buy | Grant | 45 | $1K | 12/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 365 | $10K | 12/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 45 | $1K | 9/15/2025 | View on chart |
| ASB | ▲ Buy | Grant | 361 | $9K | 9/15/2025 | View on chart |
| WEYS | ▲ Buy | Grant | 1,890 | $0 | 8/25/2025 | View on chart |
| ASB | ▲ Buy | Grant | 50 | $1K | 6/16/2025 | View on chart |
| ASB | ▲ Buy | Grant | 404 | $9K | 6/16/2025 | View on chart |
| ASB | ▲ Buy | Grant | 51 | $1K | 3/17/2025 | View on chart |
| ASB | ▲ Buy | Grant | 414 | $9K | 3/17/2025 | View on chart |
| ASB | ▲ Buy | Grant | 4,972 | $125K | 2/1/2025 | View on chart |
| ASB | ▲ Buy | Grant | 55 | $1K | 12/16/2024 | View on chart |
| ASB | ▲ Buy | Grant | 355 | $9K | 12/16/2024 | View on chart |
| ASB | ▲ Buy | Grant | 63 | $1K | 9/16/2024 | View on chart |
| ASB | ▲ Buy | Grant | 403 | $9K | 9/16/2024 | View on chart |
| WEYS | ▲ Buy | Grant | 1,550 | $0 | 8/26/2024 | View on chart |
| ASB | ▲ Buy | Grant | 65 | $1K | 6/17/2024 | View on chart |
| ASB | ▲ Buy | Grant | 422 | $9K | 6/17/2024 | View on chart |
| ASB | ▲ Buy | Grant | 65 | $1K | 3/15/2024 | View on chart |
| ASB | ▲ Buy | Grant | 418 | $8K | 3/15/2024 | View on chart |
| ASB | ▲ Buy | Grant | 5,998 | $125K | 2/1/2024 | View on chart |
| ASB | ▲ Buy | Grant | 59 | $1K | 12/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 394 | $8K | 12/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 448 | $8K | 9/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 66 | $1K | 9/15/2023 | View on chart |
| WEYS | ▲ Buy | Grant | 1,000 | $0 | 8/25/2023 | View on chart |
| ASB | ▲ Buy | Grant | 67 | $1K | 6/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 520 | $9K | 6/15/2023 | View on chart |
| WEYS | ▲ Buy | Option Exercise | 3,500 | $90K | 5/23/2023 | View on chart |
| WEYS | ▲ Buy | Option Exercise | 3,500 | $89K | 5/23/2023 | View on chart |
| WEYS | ▼ Sell | Tax Withholding | 6,463 | $179K | 5/23/2023 | View on chart |
| ASB | ▲ Buy | Grant | 401 | $8K | 3/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 60 | $1K | 3/15/2023 | View on chart |
| ASB | ▲ Buy | Grant | 5,499 | $125K | 2/1/2023 | View on chart |
| ASB | ▲ Buy | Grant | 344 | $8K | 12/15/2022 | View on chart |
| ASB | ▲ Buy | Grant | 47 | $1K | 12/15/2022 | View on chart |
| ASB | ▲ Buy | Grant | 341 | $7K | 9/15/2022 | View on chart |
| ASB | ▲ Buy | Grant | 47 | $993 | 9/15/2022 | View on chart |
| WEYS | ▲ Buy | Grant | 1,000 | $0 | 8/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Barclays Raises ASB Price Target to $35, Maintains Overweight
Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.
Barclays Raises ASB Price Target to $35, Maintains Overweight. Barclays has raised its price target for Associated Banc-Corp to $35 while maintaining an Overweight rating. This move aligns with the broader analyst consensus, where the average target is $34.20. The stock is currently trading near its 52-week high, reflecting recent strength compared to some finance peers. Investors are also awaiting the company's third-quarter earnings report scheduled for late October.